 | • レポートコード：QYR2104Z4326 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、希少疾患のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生態、血液、神経、内分泌、循環器、呼吸器、免疫療法、その他）、用途別市場規模（病院薬局、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・希少疾患の市場動向 ・企業の競争状況、市場シェア ・希少疾患の種類別市場規模（生態、血液、神経、内分泌、循環器、呼吸器、免疫療法、その他） ・希少疾患の用途別市場規模（病院薬局、ドラッグストア、その他） ・希少疾患の北米市場規模2016-2027（アメリカ、カナダ） ・希少疾患のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・希少疾患のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・希少疾患の中南米市場規模2016-2027（メキシコ、ブラジル） ・希少疾患の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bristol-Myers Squibb、Novartis、Celgene、Roche、Pfizer、Alexion、Sanofi、Vertex Pharmaceuticals、GlaxoSmithKline、Merck、Abbvie） ・結論 |
An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig’s disease, and Tourette’s syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or “gigantism.” Some diseases have patient populations of fewer than a hundred.
New rare diseases are discovered every year. Most are inherited and caused by alterations or defects in genes (mutations). Others can be acquired as a result of environmental and toxic conditions. Genes are pieces of DNA, part of the code that determines the traits and individual characteristics of all living things.
Market Analysis and Insights: Global Orphan Diseases Market
The global Orphan Diseases market size is projected to reach US$ 592.7 million by 2026, from US$ 233.7 million in 2019, at a CAGR of 14.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Orphan Diseases market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Orphan Diseases market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Orphan Diseases market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Orphan Diseases market.
Global Orphan Diseases Scope and Market Size
Orphan Diseases market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Orphan Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Therapy Area Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Therapy Area Type
Ocology
Hematology
Neurology
Endocrinology
Cardiovascular
Respiratory
Immunotherapy
Others
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bristol-Myers Squibb
Novartis
Celgene
Roche
Pfizer
Alexion
Sanofi
Vertex Pharmaceuticals
GlaxoSmithKline
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Orphan Diseases Market Size Growth Rate by Therapy Area Type: 2016 VS 2021 VS 2027
1.2.2 Ocology
1.2.3 Hematology
1.2.4 Neurology
1.2.5 Endocrinology
1.2.6 Cardiovascular
1.2.7 Respiratory
1.2.8 Immunotherapy
1.2.9 Others
1.3 Market by Application
1.3.1 Global Orphan Diseases Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Orphan Diseases Market Perspective (2016-2027)
2.2 Orphan Diseases Growth Trends by Regions
2.2.1 Orphan Diseases Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Orphan Diseases Historic Market Share by Regions (2016-2021)
2.2.3 Orphan Diseases Forecasted Market Size by Regions (2022-2027)
2.3 Orphan Diseases Industry Dynamic
2.3.1 Orphan Diseases Market Trends
2.3.2 Orphan Diseases Market Drivers
2.3.3 Orphan Diseases Market Challenges
2.3.4 Orphan Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Orphan Diseases Players by Revenue
3.1.1 Global Top Orphan Diseases Players by Revenue (2016-2021)
3.1.2 Global Orphan Diseases Revenue Market Share by Players (2016-2021)
3.2 Global Orphan Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Orphan Diseases Revenue
3.4 Global Orphan Diseases Market Concentration Ratio
3.4.1 Global Orphan Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Orphan Diseases Revenue in 2020
3.5 Orphan Diseases Key Players Head office and Area Served
3.6 Key Players Orphan Diseases Product Solution and Service
3.7 Date of Enter into Orphan Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Orphan Diseases Breakdown Data by Therapy Area Type
4.1 Global Orphan Diseases Historic Market Size by Therapy Area Type (2016-2021)
4.2 Global Orphan Diseases Forecasted Market Size by Therapy Area Type (2022-2027)
5 Orphan Diseases Breakdown Data by Application
5.1 Global Orphan Diseases Historic Market Size by Application (2016-2021)
5.2 Global Orphan Diseases Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Orphan Diseases Market Size (2016-2027)
6.2 North America Orphan Diseases Market Size by Therapy Area Type
6.2.1 North America Orphan Diseases Market Size by Therapy Area Type (2016-2021)
6.2.2 North America Orphan Diseases Market Size by Therapy Area Type (2022-2027)
6.2.3 North America Orphan Diseases Market Size by Therapy Area Type (2016-2027)
6.3 North America Orphan Diseases Market Size by Application
6.3.1 North America Orphan Diseases Market Size by Application (2016-2021)
6.3.2 North America Orphan Diseases Market Size by Application (2022-2027)
6.3.3 North America Orphan Diseases Market Size by Application (2016-2027)
6.4 North America Orphan Diseases Market Size by Country
6.4.1 North America Orphan Diseases Market Size by Country (2016-2021)
6.4.2 North America Orphan Diseases Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Orphan Diseases Market Size (2016-2027)
7.2 Europe Orphan Diseases Market Size by Therapy Area Type
7.2.1 Europe Orphan Diseases Market Size by Therapy Area Type (2016-2021)
7.2.2 Europe Orphan Diseases Market Size by Therapy Area Type (2022-2027)
7.2.3 Europe Orphan Diseases Market Size by Therapy Area Type (2016-2027)
7.3 Europe Orphan Diseases Market Size by Application
7.3.1 Europe Orphan Diseases Market Size by Application (2016-2021)
7.3.2 Europe Orphan Diseases Market Size by Application (2022-2027)
7.3.3 Europe Orphan Diseases Market Size by Application (2016-2027)
7.4 Europe Orphan Diseases Market Size by Country
7.4.1 Europe Orphan Diseases Market Size by Country (2016-2021)
7.4.2 Europe Orphan Diseases Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Orphan Diseases Market Size (2016-2027)
8.2 Asia-Pacific Orphan Diseases Market Size by Therapy Area Type
8.2.1 Asia-Pacific Orphan Diseases Market Size by Therapy Area Type (2016-2021)
8.2.2 Asia-Pacific Orphan Diseases Market Size by Therapy Area Type (2022-2027)
8.2.3 Asia-Pacific Orphan Diseases Market Size by Therapy Area Type (2016-2027)
8.3 Asia-Pacific Orphan Diseases Market Size by Application
8.3.1 Asia-Pacific Orphan Diseases Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Orphan Diseases Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Orphan Diseases Market Size by Application (2016-2027)
8.4 Asia-Pacific Orphan Diseases Market Size by Region
8.4.1 Asia-Pacific Orphan Diseases Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Orphan Diseases Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Orphan Diseases Market Size (2016-2027)
9.2 Latin America Orphan Diseases Market Size by Therapy Area Type
9.2.1 Latin America Orphan Diseases Market Size by Therapy Area Type (2016-2021)
9.2.2 Latin America Orphan Diseases Market Size by Therapy Area Type (2022-2027)
9.2.3 Latin America Orphan Diseases Market Size by Therapy Area Type (2016-2027)
9.3 Latin America Orphan Diseases Market Size by Application
9.3.1 Latin America Orphan Diseases Market Size by Application (2016-2021)
9.3.2 Latin America Orphan Diseases Market Size by Application (2022-2027)
9.3.3 Latin America Orphan Diseases Market Size by Application (2016-2027)
9.4 Latin America Orphan Diseases Market Size by Country
9.4.1 Latin America Orphan Diseases Market Size by Country (2016-2021)
9.4.2 Latin America Orphan Diseases Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Orphan Diseases Market Size (2016-2027)
10.2 Middle East & Africa Orphan Diseases Market Size by Therapy Area Type
10.2.1 Middle East & Africa Orphan Diseases Market Size by Therapy Area Type (2016-2021)
10.2.2 Middle East & Africa Orphan Diseases Market Size by Therapy Area Type (2022-2027)
10.2.3 Middle East & Africa Orphan Diseases Market Size by Therapy Area Type (2016-2027)
10.3 Middle East & Africa Orphan Diseases Market Size by Application
10.3.1 Middle East & Africa Orphan Diseases Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Orphan Diseases Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Orphan Diseases Market Size by Application (2016-2027)
10.4 Middle East & Africa Orphan Diseases Market Size by Country
10.4.1 Middle East & Africa Orphan Diseases Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Orphan Diseases Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Details
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Orphan Diseases Introduction
11.1.4 Bristol-Myers Squibb Revenue in Orphan Diseases Business (2016-2021)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Orphan Diseases Introduction
11.2.4 Novartis Revenue in Orphan Diseases Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Celgene
11.3.1 Celgene Company Details
11.3.2 Celgene Business Overview
11.3.3 Celgene Orphan Diseases Introduction
11.3.4 Celgene Revenue in Orphan Diseases Business (2016-2021)
11.3.5 Celgene Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Orphan Diseases Introduction
11.4.4 Roche Revenue in Orphan Diseases Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Orphan Diseases Introduction
11.5.4 Pfizer Revenue in Orphan Diseases Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Alexion
11.6.1 Alexion Company Details
11.6.2 Alexion Business Overview
11.6.3 Alexion Orphan Diseases Introduction
11.6.4 Alexion Revenue in Orphan Diseases Business (2016-2021)
11.6.5 Alexion Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Orphan Diseases Introduction
11.7.4 Sanofi Revenue in Orphan Diseases Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Vertex Pharmaceuticals
11.8.1 Vertex Pharmaceuticals Company Details
11.8.2 Vertex Pharmaceuticals Business Overview
11.8.3 Vertex Pharmaceuticals Orphan Diseases Introduction
11.8.4 Vertex Pharmaceuticals Revenue in Orphan Diseases Business (2016-2021)
11.8.5 Vertex Pharmaceuticals Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Orphan Diseases Introduction
11.9.4 GlaxoSmithKline Revenue in Orphan Diseases Business (2016-2021)
11.9.5 GlaxoSmithKline Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Orphan Diseases Introduction
11.10.4 Merck Revenue in Orphan Diseases Business (2016-2021)
11.10.5 Merck Recent Development
11.11 Abbvie
11.11.1 Abbvie Company Details
11.11.2 Abbvie Business Overview
11.11.3 Abbvie Orphan Diseases Introduction
11.11.4 Abbvie Revenue in Orphan Diseases Business (2016-2021)
11.11.5 Abbvie Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Orphan Diseases Market Size Growth Rate by Therapy Area Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Ocology
Table 3. Key Players of Hematology
Table 4. Key Players of Neurology
Table 5. Key Players of Endocrinology
Table 6. Key Players of Cardiovascular
Table 7. Key Players of Respiratory
Table 8. Key Players of Immunotherapy
Table 9. Key Players of Others
Table 10. Global Orphan Diseases Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Orphan Diseases Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Orphan Diseases Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Orphan Diseases Market Share by Regions (2016-2021)
Table 14. Global Orphan Diseases Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Orphan Diseases Market Share by Regions (2022-2027)
Table 16. Orphan Diseases Market Trends
Table 17. Orphan Diseases Market Drivers
Table 18. Orphan Diseases Market Challenges
Table 19. Orphan Diseases Market Restraints
Table 20. Global Orphan Diseases Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Orphan Diseases Market Share by Players (2016-2021)
Table 22. Global Top Orphan Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orphan Diseases as of 2020)
Table 23. Ranking of Global Top Orphan Diseases Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Orphan Diseases Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Orphan Diseases Product Solution and Service
Table 27. Date of Enter into Orphan Diseases Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Orphan Diseases Market Size by Therapy Area Type (2016-2021) (US$ Million)
Table 30. Global Orphan Diseases Revenue Market Share by Therapy Area Type (2016-2021)
Table 31. Global Orphan Diseases Forecasted Market Size by Therapy Area Type (2022-2027) (US$ Million)
Table 32. Global Orphan Diseases Revenue Market Share by Therapy Area Type (2022-2027) & (US$ Million)
Table 33. Global Orphan Diseases Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Orphan Diseases Revenue Market Share by Application (2016-2021)
Table 35. Global Orphan Diseases Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Orphan Diseases Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Orphan Diseases Market Size by Therapy Area Type (2016-2021) (US$ Million)
Table 38. North America Orphan Diseases Market Size by Therapy Area Type (2022-2027) & (US$ Million)
Table 39. North America Orphan Diseases Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Orphan Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Orphan Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Orphan Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Orphan Diseases Market Size by Therapy Area Type (2016-2021) (US$ Million)
Table 44. Europe Orphan Diseases Market Size by Therapy Area Type (2022-2027) & (US$ Million)
Table 45. Europe Orphan Diseases Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Orphan Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Orphan Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Orphan Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Orphan Diseases Market Size by Therapy Area Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Orphan Diseases Market Size by Therapy Area Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Orphan Diseases Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Orphan Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Orphan Diseases Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Orphan Diseases Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Orphan Diseases Market Size by Therapy Area Type (2016-2021) (US$ Million)
Table 56. Latin America Orphan Diseases Market Size by Therapy Area Type (2022-2027) & (US$ Million)
Table 57. Latin America Orphan Diseases Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Orphan Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Orphan Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Orphan Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Orphan Diseases Market Size by Therapy Area Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Orphan Diseases Market Size by Therapy Area Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Orphan Diseases Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Orphan Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Orphan Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Orphan Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 67. Bristol-Myers Squibb Company Details
Table 68. Bristol-Myers Squibb Business Overview
Table 69. Bristol-Myers Squibb Orphan Diseases Product
Table 70. Bristol-Myers Squibb Revenue in Orphan Diseases Business (2016-2021) & (US$ Million)
Table 71. Bristol-Myers Squibb Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Orphan Diseases Product
Table 75. Novartis Revenue in Orphan Diseases Business (2016-2021) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Celgene Company Details
Table 78. Celgene Business Overview
Table 79. Celgene Orphan Diseases Product
Table 80. Celgene Revenue in Orphan Diseases Business (2016-2021) & (US$ Million)
Table 81. Celgene Recent Development
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche Orphan Diseases Product
Table 85. Roche Revenue in Orphan Diseases Business (2016-2021) & (US$ Million)
Table 86. Roche Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Orphan Diseases Product
Table 90. Pfizer Revenue in Orphan Diseases Business (2016-2021) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Alexion Company Details
Table 93. Alexion Business Overview
Table 94. Alexion Orphan Diseases Product
Table 95. Alexion Revenue in Orphan Diseases Business (2016-2021) & (US$ Million)
Table 96. Alexion Recent Development
Table 97. Sanofi Company Details
Table 98. Sanofi Business Overview
Table 99. Sanofi Orphan Diseases Product
Table 100. Sanofi Revenue in Orphan Diseases Business (2016-2021) & (US$ Million)
Table 101. Sanofi Recent Development
Table 102. Vertex Pharmaceuticals Company Details
Table 103. Vertex Pharmaceuticals Business Overview
Table 104. Vertex Pharmaceuticals Revenue in Orphan Diseases Business (2016-2021) & (US$ Million)
Table 105. Vertex Pharmaceuticals Recent Development
Table 106. GlaxoSmithKline Company Details
Table 107. GlaxoSmithKline Business Overview
Table 108. GlaxoSmithKline Orphan Diseases Product
Table 109. GlaxoSmithKline Revenue in Orphan Diseases Business (2016-2021) & (US$ Million)
Table 110. GlaxoSmithKline Recent Development
Table 111. Merck Company Details
Table 112. Merck Business Overview
Table 113. Merck Orphan Diseases Product
Table 114. Merck Revenue in Orphan Diseases Business (2016-2021) & (US$ Million)
Table 115. Merck Recent Development
Table 116. Abbvie Company Details
Table 117. Abbvie Business Overview
Table 118. Abbvie Orphan Diseases Product
Table 119. Abbvie Revenue in Orphan Diseases Business (2016-2021) & (US$ Million)
Table 120. Abbvie Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Orphan Diseases Market Share by Therapy Area Type: 2020 VS 2027
Figure 2. Ocology Features
Figure 3. Hematology Features
Figure 4. Neurology Features
Figure 5. Endocrinology Features
Figure 6. Cardiovascular Features
Figure 7. Respiratory Features
Figure 8. Immunotherapy Features
Figure 9. Others Features
Figure 10. Global Orphan Diseases Market Share by Application: 2020 VS 2027
Figure 11. Hospital Pharmacy Case Studies
Figure 12. Retail Pharmacy Case Studies
Figure 13. Others Case Studies
Figure 14. Orphan Diseases Report Years Considered
Figure 15. Global Orphan Diseases Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Orphan Diseases Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Orphan Diseases Market Share by Regions: 2020 VS 2027
Figure 18. Global Orphan Diseases Market Share by Regions (2022-2027)
Figure 19. Global Orphan Diseases Market Share by Players in 2020
Figure 20. Global Top Orphan Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orphan Diseases as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Orphan Diseases Revenue in 2020
Figure 22. Global Orphan Diseases Revenue Market Share by Therapy Area Type (2016-2021)
Figure 23. Global Orphan Diseases Revenue Market Share by Therapy Area Type (2022-2027)
Figure 24. North America Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Orphan Diseases Market Share by Therapy Area Type (2016-2027)
Figure 26. North America Orphan Diseases Market Share by Application (2016-2027)
Figure 27. North America Orphan Diseases Market Share by Country (2016-2027)
Figure 28. United States Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Orphan Diseases Market Share by Therapy Area Type (2016-2027)
Figure 32. Europe Orphan Diseases Market Share by Application (2016-2027)
Figure 33. Europe Orphan Diseases Market Share by Country (2016-2027)
Figure 34. Germany Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Orphan Diseases Market Share by Therapy Area Type (2016-2027)
Figure 42. Asia-Pacific Orphan Diseases Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Orphan Diseases Market Share by Region (2016-2027)
Figure 44. China Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Orphan Diseases Market Share by Therapy Area Type (2016-2027)
Figure 52. Latin America Orphan Diseases Market Share by Application (2016-2027)
Figure 53. Latin America Orphan Diseases Market Share by Country (2016-2027)
Figure 54. Mexico Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Orphan Diseases Market Share by Therapy Area Type (2016-2027)
Figure 58. Middle East & Africa Orphan Diseases Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Orphan Diseases Market Share by Country (2016-2027)
Figure 60. Turkey Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Orphan Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Orphan Diseases Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Orphan Diseases Business (2016-2021)
Figure 65. Celgene Revenue Growth Rate in Orphan Diseases Business (2016-2021)
Figure 66. Roche Revenue Growth Rate in Orphan Diseases Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in Orphan Diseases Business (2016-2021)
Figure 68. Alexion Revenue Growth Rate in Orphan Diseases Business (2016-2021)
Figure 69. Sanofi Revenue Growth Rate in Orphan Diseases Business (2016-2021)
Figure 70. Vertex Pharmaceuticals Revenue Growth Rate in Orphan Diseases Business (2016-2021)
Figure 71. GlaxoSmithKline Revenue Growth Rate in Orphan Diseases Business (2016-2021)
Figure 72. Merck Revenue Growth Rate in Orphan Diseases Business (2016-2021)
Figure 73. Abbvie Revenue Growth Rate in Orphan Diseases Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界の孤児肺疾患治療市場規模・現状・予測（2021年-2027年） Orphan illnesses are those which are not generally looked into, those where particular medicines are not accessible, and those which may just be of restricted enthusiasm to researchers and specialists. Orphan lung diseases are exemplified by the purported disregarded infectious diseases, which are e…- 世界の後天性孤児造血疾患治療市場規模・現状・予測（2021年-2027年） Acquired orphan blood disease is a type of rare blood disorder, which occurs due to the presence of insufficient amount of red blood cells in the blood. This disease is characterized by the body’s inability to produce red blood cells. Moreover, improper functioning of bone marrow also leads to lack …
- 世界の呼吸器疾患診断検査市場規模・現状・予測（2021年-2027年） Respiratory Diseases Diagnostic Testing is the procedure to test if the patient have the Respiratory Diseases Market Analysis and Insights: Global Respiratory Diseases Diagnostic Testing Market The global Respiratory Diseases Diagnostic Testing market size is projected to reach US$ XX million by 202…
- 世界の呼吸器疾患診断検査市場規模・現状・予測（2021年-2027年） Respiratory Diseases Diagnostic Testing is the procedure to test if the patient have the Respiratory Diseases Market Analysis and Insights: Global Respiratory Diseases Diagnostic Testing Market The global Respiratory Diseases Diagnostic Testing market size is projected to reach US$ XX million by 202…
- 世界の運動ニューロン病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Motor Neuron Diseases Treatment Market The global Motor Neuron Diseases Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…